Commodore Capital Investor
Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
Technology:
Cell_Therapies
Industry:
Longevity Industry 2022
Headquarters:
New York, New York, United States
Founded Date:
2019-01-01
Employees Number:
1-10
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture
Number Of Exits:
12
Acquisitions Number:
5
Register and Claim Ownership